Table 1.
Baseline patients' characteristics.
| Overall (n=400) | Barotrauma group (n=200) | Controls (n=200) | p-value | |
|---|---|---|---|---|
| Males, n (%) | 295 (73.8) | 155 (77.5) | 140 (70) | 0.088 |
| Age, years, median (IQR) | 68 (59-75) | 69.5 (62-76) | 66.5 (57-75) | 0.022 |
| BMI, median (IQR) | 26.7 (24.5-30.4) | 26.3 (24.5-30.1) | 27.1 (24.4-30.7) | 0.466 |
| Cardiovascular disease, n/N (%) | 196/399 (49.1) | 103 (51.5) | 93/199 (46.7) | 0.341 |
| COPD, n/N (%) | 39/399 (9.8) | 15 (7.5) | 24/199 (12.1) | 0.125 |
| Solid cancer, n(%) | 31/399 (7.8) | 14 (7) | 17/199 (8.5) | 0.565 |
| Haematologic disease, n(%) | 29 (7.3) | 16 (8) | 13 (6.5) | 0.563 |
| Diabetes, n/N (%) | 84 (21) | 42 (21) | 42 (21) | 1.000 |
| CKD, n/N (%) | 37/399 (9.3) | 21 (10.5) | 16/199 (8.0) | 0.397 |
| Iatrogenic immunosuppression, n/N (%) | 29/399 (7.3) | 21 (10.5) | 8/199 (4.0) | 0.013 |
| Liver disease, n(%) | 7 (1.8) | 0 (0) | 7 (3.5) | 0.015 |
Legend. IQR: interquartile range; BMI: Body Mass Index; COPD: Chronic obstructive pulmonary disease: CKD: Chronic kidney disease.